Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Contrast-associated nephropathy.

Vikas R Soma1, Erdal Cavusoglu, Raghuraman Vidhun

  • 1Department of Medicine, Bronx VA Medical Center, Bronx, New York, USA.

Heart Disease (Hagerstown, Md.)
|November 21, 2002
PubMed
Summary

Contrast-associated nephropathy (CaN), a cause of acute kidney injury, is linked to contrast media. Prevention strategies, including hydration and new agents, are key to reducing CaN incidence.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Precision Medicine for Anticoagulation Strategies in the Cath Lab: Part 1.

Current cardiology reports·2026
Same author

Heart Failure Pharmacotherapy Across the TAVR Continuum.

Journal of cardiac failure·2026
Same author

Serial OCT-based coronary physiology and plaque composition in vessels with nonobstructive coronary lesions following intensive lipid-lowering therapy: YELLOW III sub-study.

Atherosclerosis·2026
Same author

TAVR in a Small Surgical Bioprosthesis With a Kinked Aortic Graft Using an Intra-Annular Self-Expanding Valve.

JACC. Case reports·2026
Same author

Sex differences in reverse remodeling after transcatheter aortic valve replacement in low-flow aortic stenosis.

The Journal of invasive cardiology·2026
Same author

Intra-coronary imaging and transcriptomics of calcified nodules before and after intensive lipid-lowering therapy: a YELLOW III substudy.

European heart journal. Imaging methods and practice·2026

Area of Science:

  • Nephrology
  • Radiology
  • Pharmacology

Background:

  • Contrast-associated nephropathy (CaN) is a significant cause of iatrogenic acute kidney injury.
  • It is associated with increased patient morbidity and mortality.
  • CaN incidence rises with contrast media use in diagnostic and interventional procedures.

Purpose of the Study:

  • To review the causes and risk factors of contrast-associated nephropathy.
  • To discuss current and emerging strategies for CaN prevention.

Main Methods:

  • Review of existing literature on contrast-associated nephropathy.
  • Analysis of risk factors and preventive measures for CaN.

Main Results:

  • Renal medullary ischemia and direct tubular cytotoxicity are implicated in CaN.

Related Experiment Videos

  • Key risk factors include pre-existing renal impairment, diabetes mellitus, and contrast volume.
  • Intravenous hydration remains the most effective preventive measure.

    • Conclusions:

    • Identifying and managing risk factors before contrast administration is crucial for CaN prevention.
    • New preventive agents like acetylcysteine, endothelin blockers, and fenoldopam offer additional options.
    • A multi-faceted approach combining hydration and newer agents can mitigate CaN risk.